vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
Metallus Inc. is the larger business by last-quarter revenue ($267.3M vs $196.0M, roughly 1.4× Axsome Therapeutics, Inc.). Metallus Inc. runs the higher net margin — -5.3% vs -14.6%, a 9.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 11.1%). Axsome Therapeutics, Inc. produced more free cash flow last quarter ($-18.7M vs $-37.2M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -8.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AXSM vs MTUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $267.3M |
| Net Profit | $-28.6M | $-14.3M |
| Gross Margin | — | 2.2% |
| Operating Margin | -13.8% | -7.7% |
| Net Margin | -14.6% | -5.3% |
| Revenue YoY | 65.0% | 11.1% |
| Net Profit YoY | 61.9% | 33.2% |
| EPS (diluted) | $-0.55 | $-0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $267.3M | ||
| Q3 25 | $171.0M | $305.9M | ||
| Q2 25 | $150.0M | $304.6M | ||
| Q1 25 | $121.5M | $280.5M | ||
| Q4 24 | $118.8M | $240.5M | ||
| Q3 24 | $104.8M | $227.2M | ||
| Q2 24 | $87.2M | $294.7M | ||
| Q1 24 | $75.0M | $321.6M |
| Q4 25 | $-28.6M | $-14.3M | ||
| Q3 25 | $-47.2M | $8.1M | ||
| Q2 25 | $-48.0M | $3.7M | ||
| Q1 25 | $-59.4M | $1.3M | ||
| Q4 24 | $-74.9M | $-21.4M | ||
| Q3 24 | $-64.6M | $-5.9M | ||
| Q2 24 | $-79.3M | $4.6M | ||
| Q1 24 | $-68.4M | $24.0M |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 15.7% |
| Q4 25 | -13.8% | -7.7% | ||
| Q3 25 | -27.0% | 3.6% | ||
| Q2 25 | -24.5% | 2.8% | ||
| Q1 25 | -46.9% | 1.0% | ||
| Q4 24 | -61.1% | -10.1% | ||
| Q3 24 | -59.8% | -3.1% | ||
| Q2 24 | -89.5% | 2.1% | ||
| Q1 24 | -89.7% | 9.3% |
| Q4 25 | -14.6% | -5.3% | ||
| Q3 25 | -27.6% | 2.6% | ||
| Q2 25 | -32.0% | 1.2% | ||
| Q1 25 | -48.9% | 0.5% | ||
| Q4 24 | -63.1% | -8.9% | ||
| Q3 24 | -61.7% | -2.6% | ||
| Q2 24 | -91.0% | 1.6% | ||
| Q1 24 | -91.1% | 7.5% |
| Q4 25 | $-0.55 | $-0.34 | ||
| Q3 25 | $-0.94 | $0.19 | ||
| Q2 25 | $-0.97 | $0.09 | ||
| Q1 25 | $-1.22 | $0.03 | ||
| Q4 24 | $-1.54 | $-0.46 | ||
| Q3 24 | $-1.34 | $-0.13 | ||
| Q2 24 | $-1.67 | $0.10 | ||
| Q1 24 | $-1.44 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $686.0M |
| Total Assets | $689.8M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $156.7M | ||
| Q3 25 | $325.3M | $191.5M | ||
| Q2 25 | $303.0M | $190.8M | ||
| Q1 25 | $300.9M | $180.3M | ||
| Q4 24 | $315.4M | $240.7M | ||
| Q3 24 | $327.3M | $254.6M | ||
| Q2 24 | $315.7M | $272.8M | ||
| Q1 24 | $331.4M | $278.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $13.2M | ||
| Q1 24 | — | $13.2M |
| Q4 25 | $88.3M | $686.0M | ||
| Q3 25 | $73.7M | $697.7M | ||
| Q2 25 | $73.1M | $690.0M | ||
| Q1 25 | $53.2M | $686.1M | ||
| Q4 24 | $57.0M | $690.5M | ||
| Q3 24 | $92.9M | $712.7M | ||
| Q2 24 | $102.9M | $736.3M | ||
| Q1 24 | $144.0M | $739.3M |
| Q4 25 | $689.8M | $1.1B | ||
| Q3 25 | $669.3M | $1.2B | ||
| Q2 25 | $639.8M | $1.1B | ||
| Q1 25 | $596.7M | $1.1B | ||
| Q4 24 | $568.5M | $1.1B | ||
| Q3 24 | $561.5M | $1.1B | ||
| Q2 24 | $548.2M | $1.1B | ||
| Q1 24 | $545.7M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-1.9M |
| Free Cash FlowOCF − Capex | $-18.7M | $-37.2M |
| FCF MarginFCF / Revenue | -9.6% | -13.9% |
| Capex IntensityCapex / Revenue | 0.0% | 13.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-1.9M | ||
| Q3 25 | $1.0M | $22.0M | ||
| Q2 25 | $-32.4M | $34.8M | ||
| Q1 25 | $-43.4M | $-38.9M | ||
| Q4 24 | $-26.2M | $13.9M | ||
| Q3 24 | $-18.6M | $-15.3M | ||
| Q2 24 | $-30.1M | $8.3M | ||
| Q1 24 | $-53.5M | $33.4M |
| Q4 25 | $-18.7M | $-37.2M | ||
| Q3 25 | $988.0K | $-6.4M | ||
| Q2 25 | $-32.4M | $17.0M | ||
| Q1 25 | $-43.7M | $-66.4M | ||
| Q4 24 | $-26.2M | $-1.3M | ||
| Q3 24 | $-18.7M | $-32.9M | ||
| Q2 24 | $-30.2M | $-5.8M | ||
| Q1 24 | $-53.6M | $16.0M |
| Q4 25 | -9.6% | -13.9% | ||
| Q3 25 | 0.6% | -2.1% | ||
| Q2 25 | -21.6% | 5.6% | ||
| Q1 25 | -36.0% | -23.7% | ||
| Q4 24 | -22.1% | -0.5% | ||
| Q3 24 | -17.9% | -14.5% | ||
| Q2 24 | -34.6% | -2.0% | ||
| Q1 24 | -71.4% | 5.0% |
| Q4 25 | 0.0% | 13.2% | ||
| Q3 25 | 0.0% | 9.3% | ||
| Q2 25 | 0.0% | 5.8% | ||
| Q1 25 | 0.3% | 9.8% | ||
| Q4 24 | 0.0% | 6.3% | ||
| Q3 24 | 0.1% | 7.7% | ||
| Q2 24 | 0.1% | 4.8% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.72× | ||
| Q2 25 | — | 9.41× | ||
| Q1 25 | — | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
MTUS
| Industrial Market Sector | $95.3M | 36% |
| Manufactured Components | $67.8M | 25% |
| Aerospace And Defense | $39.6M | 15% |
| Seamless Mechanical Tubing | $31.3M | 12% |
| Energy Market Sector | $18.3M | 7% |
| Other | $11.3M | 4% |
| Other Market Sector | $3.7M | 1% |
